DBV Technologies announced the appointment of Ramzi Benamar as its Chief Financial Officer, effective January 6, 2020. Ramzi will serve as a member of the Executive Committee and report to Daniel Tassé, Chief Executive Officer of DBV Technologies. Ramzi brings more than two decades of experience in biopharmaceutical finance and business operations roles.

He most recently served as Vice President and Head of Financial Planning and Analysis for Spark Therapeutics, where he reported directly to the CFO, providing financial leadership across the company and supporting the design and implementation of product launch plans, including pricing strategy, marketing, sales, market access, contracting and distribution. Previously, Ramzi held various positions of increasing responsibilities in R&D finance, as well as in Analytics, Strategy and Operations at Merck, Johnson & Johnson and Shire Plc.